A citation-based method for searching scientific literature

Viviane de Sousa Tomaz, Adriano José Maia Chaves Filho, Rafaela Carneiro Cordeiro, Paloma Marinho Jucá, Michelle Verde Ramo Soares, Poliana Noronha Barroso, Larissa Maria Frota Cristino, Wei Jiang, Antônio Lúcio Teixeira, David F de Lucena, Danielle S Macedo. J Affect Disord 2020
Times Cited: 19







List of co-cited articles
110 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Vortioxetine exerts anti-inflammatory and immunomodulatory effects on human monocytes/macrophages.
Maria Talmon, Silvia Rossi, Anna Pastore, Carlo Ignazio Cattaneo, Sandra Brunelleschi, Luigia Grazia Fresu. Br J Pharmacol 2018
19
26



Biomarkers for response in major depression: comparing paroxetine and venlafaxine from two randomised placebo-controlled clinical studies.
Lucia Carboni, Dennis J McCarthy, Bruno Delafont, Michele Filosi, Elena Ivanchenko, Emiliangelo Ratti, Susan M Learned, Robert Alexander, Enrico Domenici. Transl Psychiatry 2019
23
15



Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
Andrea Cipriani, Toshi A Furukawa, Georgia Salanti, Anna Chaimani, Lauren Z Atkinson, Yusuke Ogawa, Stefan Leucht, Henricus G Ruhe, Erick H Turner, Julian P T Higgins,[...]. Lancet 2018
803
15


A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults.
Roger S McIntyre, Søren Lophaven, Christina K Olsen. Int J Neuropsychopharmacol 2014
206
15

Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression.
I Goshen, T Kreisel, O Ben-Menachem-Zidon, T Licht, J Weidenfeld, T Ben-Hur, R Yirmiya. Mol Psychiatry 2008
488
15

Minocycline selectively inhibits M1 polarization of microglia.
K Kobayashi, S Imagama, T Ohgomori, K Hirano, K Uchimura, K Sakamoto, A Hirakawa, H Takeuchi, A Suzumura, N Ishiguro,[...]. Cell Death Dis 2013
372
15

From inflammation to sickness and depression: when the immune system subjugates the brain.
Robert Dantzer, Jason C O'Connor, Gregory G Freund, Rodney W Johnson, Keith W Kelley. Nat Rev Neurosci 2008
15



Effects of doxycycline on depressive-like behavior in mice after lipopolysaccharide (LPS) administration.
Bruna Stefânia Ferreira Mello, Aline Santos Monte, Roger S McIntyre, Joanna K Soczynska, Charllyany Sabino Custódio, Rafaela Carneiro Cordeiro, João Henrique Chaves, Silvânia Maria Mendes Vasconcelos, Hélio Vitoriano Nobre, Francisca Cléa Florenço de Sousa,[...]. J Psychiatr Res 2013
111
15

Immune mechanisms linked to depression via oxidative stress and neuroprogression.
Nataliia Bakunina, Carmine M Pariante, Patricia A Zunszain. Immunology 2015
152
10

Innate immunity in the postmortem brain of depressed and suicide subjects: Role of Toll-like receptors.
Ghanshyam N Pandey, Hooriyah S Rizavi, Runa Bhaumik, Xinguo Ren. Brain Behav Immun 2019
39
10

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.
Andrew H Miller, Vladimir Maletic, Charles L Raison. Biol Psychiatry 2009
10

SSRI Antidepressant Medications: Adverse Effects and Tolerability.
James M. Ferguson. Prim Care Companion J Clin Psychiatry 2001
317
10

Vortioxetine for Cognitive Enhancement in Major Depression: From Animal Models to Clinical Research.
Djamila Bennabi, Emmanuel Haffen, Vincent Van Waes. Front Psychiatry 2019
11
18

Risk factors for relapse and recurrence of depression in adults and how they operate: A four-phase systematic review and meta-synthesis.
J E J Buckman, A Underwood, K Clarke, R Saunders, S D Hollon, P Fearon, S Pilling. Clin Psychol Rev 2018
74
10

The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms.
Søren H Sindrup, Lars F Gram, Kim Brøsen, Ole Eshøj, Erik F Mogensen. Pain 1990
328
10


A randomized, double-blind, placebo-controlled study of the efficacy and safety of vortioxetine 10 mg and 20 mg in adults with major depressive disorder.
Paula L Jacobsen, Atul R Mahableshwarkar, Michael Serenko, Serena Chan, Madhukar H Trivedi. J Clin Psychiatry 2015
63
10

A randomized, double-blind, placebo-controlled study of the efficacy and safety of 2 doses of vortioxetine in adults with major depressive disorder.
Atul R Mahableshwarkar, Paula L Jacobsen, Michael Serenko, Yinzhong Chen, Madhukar H Trivedi. J Clin Psychiatry 2015
55
10

Enhanced long-term synaptic depression in an animal model of depression.
Roman Holderbach, Kristin Clark, Jean-Luc Moreau, Josef Bischofberger, Claus Normann. Biol Psychiatry 2007
137
10

Multimodal antidepressant vortioxetine causes analgesia in a mouse model of chronic neuropathic pain.
Anna Rita Zuena, Daniela Maftei, Giovanni Sebastiano Alemà, Francesca Dal Moro, Roberta Lattanzi, Paola Casolini, Ferdinando Nicoletti. Mol Pain 2018
11
18

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision.
N Attal, G Cruccu, R Baron, M Haanpää, P Hansson, T S Jensen, T Nurmikko. Eur J Neurol 2010
997
10

Off-label Antidepressant Use for Treatment and Management of Chronic Pain: Evolving Understanding and Comprehensive Review.
Ivan Urits, Jacquelin Peck, Mariam Salisu Orhurhu, John Wolf, Riki Patel, Vwaire Orhurhu, Alan D Kaye, Omar Viswanath. Curr Pain Headache Rep 2019
23
10


Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis.
Nanna B Finnerup, Nadine Attal, Simon Haroutounian, Ewan McNicol, Ralf Baron, Robert H Dworkin, Ian Gilron, Maija Haanpää, Per Hansson, Troels S Jensen,[...]. Lancet Neurol 2015
10

Changes in sleep predict changes in depressive symptoms in depressed subjects receiving vortioxetine: An open-label clinical trial.
Bing Cao, Caroline Park, Joshua D Rosenblat, Yan Chen, Michelle Iacobucci, Mehala Subramaniapillai, Rodrigo B Mansur, Hannah Zuckerman, Yena Lee, Roger S McIntyre. J Psychopharmacol 2019
7
28



Vortioxetine: A review of the pharmacology and clinical profile of the novel antidepressant.
Magdalena Sowa-Kućma, Patrycja Pańczyszyn-Trzewik, Paulina Misztak, Rafał R Jaeschke, Katherine Sendek, Krzysztof Styczeń, Wojciech Datka, Magdalena Koperny. Pharmacol Rep 2017
30
10

Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder.
Benny Bang-Andersen, Thomas Ruhland, Morten Jørgensen, Garrick Smith, Kristen Frederiksen, Klaus Gjervig Jensen, Huailing Zhong, Søren Møller Nielsen, Sandra Hogg, Arne Mørk,[...]. J Med Chem 2011
251
10

Duloxetine vs. placebo in patients with painful diabetic neuropathy.
David J Goldstein, Yili Lu, Michael J Detke, Thomas C Lee, Smriti Iyengar. Pain 2005
507
10

Vortioxetine: a novel antidepressant for the treatment of major depressive disorder.
Xenia Gonda, Samata R Sharma, Frank I Tarazi. Expert Opin Drug Discov 2019
21
10

The Involvement of Descending Pain Inhibitory System in Electroacupuncture-Induced Analgesia.
Qiuyi Lv, Fengzhi Wu, Xiulun Gan, Xueqin Yang, Ling Zhou, Jie Chen, Yinjia He, Rong Zhang, Bixiu Zhu, Lanying Liu. Front Integr Neurosci 2019
15
13

The association between burning mouth syndrome and sleep disturbance: A case-control multicentre study.
D Adamo, A Sardella, E Varoni, C Lajolo, M Biasotto, G Ottaviani, P Vescovi, T Simonazzi, M Pentenero, M Ardore,[...]. Oral Dis 2018
24
10

Preliminary evidence that vortioxetine may improve sleep quality in depressed patients with insomnia: a retrospective questionnaire analysis.
C Liguori, L Ferini-Strambi, F Izzi, L Mari, N Manfredi, A D'Elia, N B Mercuri, F Placidi. Br J Clin Pharmacol 2019
9
22


Vortioxetine promotes early changes in dendritic morphology compared to fluoxetine in rat hippocampus.
Fenghua Chen, Kristian Gaarn du Jardin, Jessica A Waller, Connie Sanchez, Jens R Nyengaard, Gregers Wegener. Eur Neuropsychopharmacol 2016
25
10

Vortioxetine in the Treatment of Mood Disorders Associated with Burning Mouth Syndrome: Results of an Open-Label, Flexible-Dose Pilot Study.
Daniela Adamo, Giuseppe Pecoraro, Massimo Aria, Gianfranco Favia, Michele Davide Mignogna. Pain Med 2020
9
22

Efficacy of Vortioxetine on Cognitive Functioning in Working Patients With Major Depressive Disorder.
Roger S McIntyre, Ioana Florea, Brigitte Tonnoir, Henrik Loft, Raymond W Lam, Michael Cronquist Christensen. J Clin Psychiatry 2017
43
10

Vortioxetine: Clinical Pharmacokinetics and Drug Interactions.
Grace Chen, Astrid-Maria Højer, Johan Areberg, George Nomikos. Clin Pharmacokinet 2018
28
10

Central modulation of pain.
Michael H Ossipov, Gregory O Dussor, Frank Porreca. J Clin Invest 2010
540
10

Chronic pain and medullary descending facilitation.
Frank Porreca, Michael H Ossipov, G F Gebhart. Trends Neurosci 2002
645
10

Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorder.
A Mørk, A Pehrson, L T Brennum, S Møller Nielsen, H Zhong, A B Lassen, S Miller, L Westrich, N J Boyle, C Sánchez,[...]. J Pharmacol Exp Ther 2012
188
10

Chapter 13 Descending inhibitory systems.
Antti Pertovaara, Armando Almeida. Handb Clin Neurol 2006
59
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.